177 related articles for article (PubMed ID: 15231841)
1. Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol.
Kelley EE; Trostchansky A; Rubbo H; Freeman BA; Radi R; Tarpey MM
J Biol Chem; 2004 Sep; 279(36):37231-4. PubMed ID: 15231841
[TBL] [Abstract][Full Text] [Related]
2. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production.
Malik UZ; Hundley NJ; Romero G; Radi R; Freeman BA; Tarpey MM; Kelley EE
Free Radic Biol Med; 2011 Jul; 51(1):179-84. PubMed ID: 21554948
[TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes.
Radi R; Rubbo H; Bush K; Freeman BA
Arch Biochem Biophys; 1997 Mar; 339(1):125-35. PubMed ID: 9056242
[TBL] [Abstract][Full Text] [Related]
4. A new sensitive and quantitative chemiluminescent assay to monitor intracellular xanthine oxidase activity for rapid screening of inhibitors in living endothelial cells.
Caliceti C; Calabria D; Roda A
Anal Bioanal Chem; 2016 Dec; 408(30):8755-8760. PubMed ID: 27392750
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase contributes to mechanical ventilation-induced diaphragmatic oxidative stress and contractile dysfunction.
Whidden MA; McClung JM; Falk DJ; Hudson MB; Smuder AJ; Nelson WB; Powers SK
J Appl Physiol (1985); 2009 Feb; 106(2):385-94. PubMed ID: 18974366
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease.
Landmesser U; Spiekermann S; Preuss C; Sorrentino S; Fischer D; Manes C; Mueller M; Drexler H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):943-8. PubMed ID: 17234726
[TBL] [Abstract][Full Text] [Related]
7. Why do most human liver cytosol preparations lack xanthine oxidase activity?
Barr JT; Choughule KV; Nepal S; Wong T; Chaudhry AS; Joswig-Jones CA; Zientek M; Strom SC; Schuetz EG; Thummel KE; Jones JP
Drug Metab Dispos; 2014 Apr; 42(4):695-9. PubMed ID: 24430612
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of xanthine oxidase by 4-hydroxy-6-mercaptopyrazolo[3,4-d]pyrimidine.
Spector T; Hall WW; Porter DJ; Lambe CU; Nelson DJ; Krenitsky TA
Biochem Pharmacol; 1989 Dec; 38(23):4315-20. PubMed ID: 2557043
[TBL] [Abstract][Full Text] [Related]
9. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.
Spector T
Biochem Pharmacol; 1988 Jan; 37(2):349-52. PubMed ID: 2829916
[TBL] [Abstract][Full Text] [Related]
10. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease.
Baldus S; Köster R; Chumley P; Heitzer T; Rudolph V; Ostad MA; Warnholtz A; Staude HJ; Thuneke F; Koss K; Berger J; Meinertz T; Freeman BA; Münzel T
Free Radic Biol Med; 2005 Nov; 39(9):1184-90. PubMed ID: 16214034
[TBL] [Abstract][Full Text] [Related]
11. Dietary inhibition of xanthine oxidase attenuates radiation-induced endothelial dysfunction in rat aorta.
Soucy KG; Lim HK; Attarzadeh DO; Santhanam L; Kim JH; Bhunia AK; Sevinc B; Ryoo S; Vazquez ME; Nyhan D; Shoukas AA; Berkowitz DE
J Appl Physiol (1985); 2010 May; 108(5):1250-8. PubMed ID: 20167676
[TBL] [Abstract][Full Text] [Related]
12. Oxypurinol, a xanthine oxidase inhibitor and a superoxide scavenger, did not attenuate ischemic neuronal damage in gerbils.
Arai T; Mori H; Ishii H; Adachi T; Endo N; Makino K; Mori K
Life Sci; 1998; 63(7):PL 107-12. PubMed ID: 9718087
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
Kou B; Ni J; Vatish M; Singer DR
Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
[TBL] [Abstract][Full Text] [Related]
15. Tissue protective effect of xanthine oxidase inhibitor, polymer conjugate of (styrene-maleic acid copolymer) and (4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine), on hepatic ischemia-reperfusion injury.
Fang J; Seki T; Qin H; Bharate GY; Iyer AK; Maeda H
Exp Biol Med (Maywood); 2010 Apr; 235(4):487-96. PubMed ID: 20407081
[TBL] [Abstract][Full Text] [Related]
16. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases.
Weidert ER; Schoenborn SO; Cantu-Medellin N; Choughule KV; Jones JP; Kelley EE
Nitric Oxide; 2014 Feb; 37():41-5. PubMed ID: 24406683
[TBL] [Abstract][Full Text] [Related]
18. Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium.
Kögler H; Fraser H; McCune S; Altschuld R; Marbán E
Cardiovasc Res; 2003 Sep; 59(3):582-92. PubMed ID: 14499859
[TBL] [Abstract][Full Text] [Related]
19. Effects of xanthine oxidase inhibition on ischemic acute renal failure in the rat.
Zager RA; Gmur DJ
Am J Physiol; 1989 Dec; 257(6 Pt 2):F953-8. PubMed ID: 2603962
[TBL] [Abstract][Full Text] [Related]
20. Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation.
Orriss IR; Arnett TR; George J; Witham MD
Exp Cell Res; 2016 Mar; 342(2):166-74. PubMed ID: 26968635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
